Association of Community Cancer Centers

Cancer education and advocacy organization

Based in MD

🤖

AI Overview

With $40K in lobbying spend across 34 quarterly filings, Association of Community Cancer Centers is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$40K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$20K
2019	$0
2020	$0
2021	$20K
2022	$0
2023	$0
2024	$0
2025	$0

Issues Lobbied

Health Issues Medicare/Medicaid Government Issues

Lobbying Firms

Lobbyists

Leah Ralph Blair Burnett Kristin Ferguson

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Government Issues

•Oral chemotherapy parity legislation (The Cancer Drug Parity Act of 2017 (H.R. 1409))
•Increased education and training for medical professionals in palliative care (The Palliative Care & Hospice Educa

•Excluding Part B payments from CMS' Merit Based Incentive Payment System (MIPS) adjustment under the Quality Payment Program (QPP)
•Reimbursement for care planning for cancer patients in the Medicare P

•Preserving patient protections in a repeal of the Affordable Care Act (ACA)
•Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)

•Flexibility in implementing CMS' Quality Payment Program
•Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI)

•ACCC advocated to the US House of Representatives and US Senate on the following issues: (1) passage of a federal oral parity bill in US Congress in support of H.R. 1730 (Cancer Drug Parity Act of 201